Sensei Biotherapeutics Croissance future
Future contrôle des critères 0/6
Sensei Biotherapeutics's earnings are forecast to decline at 18.9% per annum. EPS is expected to decline by 1.9% per annum.
Informations clés
-18.9%
Taux de croissance des bénéfices
-1.9%
Taux de croissance du BPA
Biotechs croissance des bénéfices | 27.1% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | -59.8% |
Couverture par les analystes | Low |
Dernière mise à jour | 03 Oct 2024 |
Mises à jour récentes de la croissance future
Recent updates
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14We're Hopeful That Sensei Biotherapeutics (NASDAQ:SNSE) Will Use Its Cash Wisely
Aug 14Sensei Biotherapeutics GAAP EPS of -$0.34 beats by $0.06
Aug 09Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Apr 18Sensei Biotherapeutics (NASDAQ:SNSE) Is In A Good Position To Deliver On Growth Plans
Nov 16Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | N/A | -44 | N/A | -49 | 2 |
12/31/2025 | N/A | -37 | N/A | -40 | 2 |
12/31/2024 | N/A | -31 | N/A | -32 | 3 |
6/30/2024 | N/A | -30 | -24 | -24 | N/A |
3/31/2024 | N/A | -32 | -28 | -28 | N/A |
12/31/2023 | N/A | -34 | -32 | -32 | N/A |
9/30/2023 | N/A | -39 | -36 | -35 | N/A |
6/30/2023 | N/A | -45 | -38 | -38 | N/A |
3/31/2023 | N/A | -46 | -40 | -40 | N/A |
12/31/2022 | N/A | -49 | -39 | -39 | N/A |
9/30/2022 | N/A | -46 | -38 | -37 | N/A |
6/30/2022 | N/A | -42 | -37 | -36 | N/A |
3/31/2022 | N/A | -41 | -32 | -30 | N/A |
12/31/2021 | N/A | -37 | -32 | -30 | N/A |
9/30/2021 | N/A | -33 | -27 | -25 | N/A |
6/30/2021 | N/A | -28 | -28 | -25 | N/A |
3/31/2021 | N/A | -23 | -24 | -22 | N/A |
12/31/2020 | N/A | -20 | -19 | -18 | N/A |
9/30/2020 | N/A | -23 | -18 | -17 | N/A |
12/31/2019 | N/A | -21 | -9 | -9 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: SNSE is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: SNSE is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: SNSE is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if SNSE's revenue is forecast to grow faster than the US market.
Croissance élevée des revenus: SNSE is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: SNSE is forecast to be unprofitable in 3 years.